A decrease in HGB can lead to tumor hypoxia, which stimulates tumor growth by stimulating angiogenesis, acquiring genome mutations, and increasing resistance to apoptosis, and further leads to increased staging and a poor prognosis [12]. This evidence concerns the gene CYGB and neoplasm.